A linear range of 4 orders of magnitude ranging from 8.5 × 10–4 to 5.6 ng mL–1 for the assay of PSA was achieved, which is highly promising for the early diagnosis of PCa and monitoring of PCa relapse of patients after radical prostatectomy. Here, KLK3 is linked to posterior cortical atrophy.